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Letter to the Editor
Association between the polymorphisms
of the selected genes encoding dopaminergic
system with ADHD and autism
Attention-deficit hyperactivity disorder (ADHD) and autism are
heritable, polygenic neurodevelopmental disorders with similar
symptoms, onset in childhood, and more frequent occurrence in
boys than in girls (Muhle et al., 2004; Wallis, 2010).
The study evaluated the association of ADHD and/or autism
with dopamine receptor D4 exon 3 variable number of tandem
repeats (DRD4 VNTR) polymorphism, catechol-o-methyltrans-
ferase (COMT Val108/158Met; rs4680), dopamine-beta-hydroxylase
(DBH -1021C/T; rs1611115) and monoamine oxidase type B (MAO-B
intron 13; rs1799836) polymorphisms in ethnically homogenous
non-related Caucasian male subjects of European (Croatian) ances-
try: 102 medication-free children (9.272.5 years old) who met
DSM-IV criteria for ADHD, 80 subjects (18.2710.3 years old) who
met DSM-IV criteria for autism, and had 43.278.9 Childhood
Autism Rating Scale scores, and 128 healthy control subjects
(16.979.0 years old). Genotyping of DRD4 VNTR was done using
polymerase chain reaction and 2% agarose gel electrophoresis, and
individuals were categorized into DRD4 long (L) allele carriers
(possessing at least one copy of 7 or more repeats allele) and short
(SS) homozygotes (possessing 2 copies of 2–6 repeats allele).
Genotyping of rs4680, rs1611115 and rs1799836 was done using
a Taqman-based allele-specific polymerase chain reaction assays
(Applied Biosystems, Foster City, CA). Subjects were categorized
into COMTMet/Met homozygous genotype vs. Val carriers, DBH CC
genotype vs. T carriers, and MAO-B A or G carriers. Results
(Table 1) were evaluated with two tailed χ2 test, standardized
residuals (RZ2.00), odds ratio (OR), 95% CI, z and Cramer's C or V
statistics. Pr0.0125 was considered significant after Bonferroni
correction for multiple comparisons.
Genotype frequencies in DRD4 VNTR in autism and healthy
controls, and in the DBH -1021C/T in ADHD (Po0.05) deviated
from Hardy–Weinberg equilibrium (HWE), while other genotype
frequencies were in the expected HWE (P>0.05). DRD4 L allele
carriers in ADHD and autistic groups and COMT Met/Met genotype
in healthy subjects contributed to the significant χ2 statistics.
There were less DRD4 L allele carriers than SS genotype carriers
in autistic subjects compared to ADHD (z¼3.324; P¼0.001;
OR¼2.4; 95% CI¼1.022–5.548) or control groups, confirming the
role of L allele in attention, and supporting the hypothesis (Grady
et al., 2005) that L allele has a major role in the etiology of ADHD,
but not in autism. More COMT Met/Met homozygotes than Val
carriers were found in groups with ADHD (z¼2.946; P¼0.003;
OR¼3.75; 95% CI¼1.951–7.200) or autism (z¼2.536; P¼0.011;
OR¼4.05; 95% CI¼2.024–8.124) than in control group, suggesting
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Table 1
The frequencies of the DBH -1021C/T, MAO-B intron 13, DRD4 VNTR and COMT Val108/158Met genotypes and the additive genetic effects of DRD4 and COMT risk genotypes
in healthy control subjects and in subjects with ADHD or autism.
Healthy subjects Subjects with ADHD Subjects with autism
N (%) N (%) N (%)
DRD4 genotype
SS 92 (71.9) 60 (58.8) 48 (85.7)
L carriers 36 (28.1) 42 (41.2) 8 (14.3)
χ2¼12.849; d.f.¼2; P¼0.002; power¼0.789; Φc¼0.21; R¼2.05 for L carriers in ADHD; R¼2.15 for L carriers in autism
COMT genotype
Met/Met 18 (14.1) 31 (30.4) 23 (28.8)
Val carriers 110 (85.9) 71 (69.6) 57 (71.2)
χ2¼10.334; d.f.¼2; P¼0.006; power¼0.662; Φc¼0.18; R¼2.15 for Met/Met homozygotes in healthy subjects
DBH genotype
CC 79 (61.7) 55 (53.9) 49 (61.2)
T carriers 49 (38.3) 47 (46.1) 31 (38.8)
χ2¼31.646; d.f.¼2; P¼0.439; power¼0.077
MAO-B genotype
G 54 (42.2) 41 (40.2) 34 (43.0)
A 74 (57.8) 61 (59.8) 45 (57.0)
χ2¼0.165; d.f.¼2; P¼0.921; power¼0.212
Additive genetic effects of DRD4 and COMT risk genotypes
0 74 (57.8) 42 (41.2) 34 (60.7)
1 51 (39.8) 47 (46.1) 19 (33.9)
2 3 (2.4) 13 (12.7) 3 (5.4)
χ2¼14.689; d.f.¼4; P¼0.005; power¼0.750; Φc¼0.23; R¼2.39 in ADHD carriers of both risk genotypes
T carriers¼CTþTT genotype; Val carriers¼Met/ValþVal/Val genotype; 0¼none, 1¼one, 2¼both risk genotypes (DRD4 VNTR L allele or COMT Met/Met genotype);
R¼standardized residuals (RZ2.00 indicated that these genotypes contributed to significant differences in χ2 test); Φc¼effect size calculated using Cramer's C or V statistics.
Due to Bonferroni correction, Pr0.0125 was considered significant.
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that subjects with ADHD and autism have deficits in prefrontal
circuits that modulate cognitive functions (Bellgrove et al., 2005).
When subjects were categorized according to none, one or both
risk genotypes (DRD4 VNTR L allele or COMT Met/Met genotype)
the additive effect of the two risk genotypes was detected in
subjects with ADHD.
Our results confirmed that DRD4 VNTR and COMT Val108/
158Met, in contrast to DBH -1021C/T or MAO-B intron 13 poly-
morphisms, are associated with ADHD and autism in smaller
ethnically homogenous groups of non-related male Caucasians,
contributing to hypothesis that both disorders have shared herit-
ability and common biological/genetic factors (Rommelse et al.,
2010).
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